Notice of 2014 Annual General Meeting in CellaVision AB

        Print
| Source: CellaVision
The shareholders in CellaVision AB are hereby summoned to the Annual General
Meeting, to be held on May 7, 2014 at 16.00 at CellaVision AB, Scheelevägen 19
A, Ideon, in Lund, Sweden.

The complete notice is available in Swedish only.

For more information, please contact:
Yvonne Mårtensson, CEO, CellaVision AB
Phone: +46 708 33 77 82 | E-mail: yvonne.martensson@cellavision.com

About CellaVision
CellaVision is an innovative, global medical technology company that develops
and sells its own leading systems for routine analysis of blood and other body
fluids in health care services. The analyses often constitute important
reference data for fast and correct diagnosis of illnesses, for example of
infections and serious cancers. CellaVision's products rationalize manual
laboratory work, and secure and support effective workflows and skills
development within and between hospitals. The company has leading-edge expertise
in image analysis, artificial intelligence and automated microscopy. In 2013
sales were SEK 180 million and sales continue to increase, with a growth target
of at least 15 % per year over an economic cycle. CellaVision's registered
office is in Lund and the company has subsidiaries in the USA, Canada and Japan.
The share is listed on the Nasdaq OMX Stockholm, Small Cap list. Read more at
www.cellavision.com


[HUG#1772648]